Cornelia Schuster

Bergen, 5009, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications

Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Assessment of Variables Related to the Risk of Severe Adverse Events in Cutaneous Melanoma Patients Treated with Immune Checkpoint Inhibitors.

Journal: Cancers
Published: December 10, 2023

β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma.

β2-adrenergic receptor expression in patients receiving bevacizumab therapy for metastatic melanoma.

Journal: Cancer medicine
Published: March 08, 2023

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.

Ipilimumab in a real-world population: A prospective Phase IV trial with long-term follow-up.

Journal: International journal of cancer
Published: May 07, 2021

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.

ctDNA detected by ddPCR reveals changes in tumour load in metastatic malignant melanoma treated with bevacizumab.

Journal: Scientific reports
Published: November 27, 2018

Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.

Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma.

Journal: PloS one
Published: October 24, 2018

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.

Predictive value of angiogenic proteins in patients with metastatic melanoma treated with bevacizumab monotherapy.

Journal: The journal of pathology. Clinical research
Published: May 08, 2018

Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.

Expression of Heat Shock Protein 27 in Melanoma Metastases Is Associated with Overall Response to Bevacizumab Monotherapy: Analyses of Predictive Markers in a Clinical Phase II Study.

Journal: PloS one
Published: November 18, 2015

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.

Clinical efficacy and safety of bevacizumab monotherapy in patients with metastatic melanoma: predictive importance of induced early hypertension.

Journal: PloS one
Published: March 16, 2012
Showing 1-8 of 8

Last Updated: 09/26/2026